Clinical Efficacy and Safety of Bempedoic Acid in High Cardiovascular Risk Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Clinical Efficacy and Safety of Bempedoic Acid in High Cardiovascular Risk Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Published:2023-12 Issue:12 Volume:48 Page:102003
ISSN:0146-2806
Container-title:Current Problems in Cardiology
language:en
Short-container-title:Current Problems in Cardiology

Author:

Uddin Naseer^ORCID,Syed Abdul Ahad,Ismail Syed Muhammad,Ashraf Muhammad Talal,Khan Muhammad Khuzzaim,Sohail Affan

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference32 articles.

1. Cardiovascular diseases (CVDs). Accessed June 28, 2023. Available at: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

2. Epidemiological aspects of heart diseases;Shi;Exp Ther Med,2016

3. Cardiovascular risk factors and prevention: a perspective from developing countries;Teo;Can J Cardiol,2021

4. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Grundy;J Am Coll Cardiol,2019

5. New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?;Atar;Atherosclerosis,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NLRP3 Inflammasome — a new universal target of asymptomatic hyperuricemia and gout management;Rational Pharmacotherapy in Cardiology;2024-06-19

2. Emerging therapies for refractory hypercholesterolemia: a narrative review;Future Cardiology;2024-04-25

3. Present and Future of Dyslipidaemia Treatment—A Review;Journal of Clinical Medicine;2023-09-08